Is Lazard (LAZ) Undervalued As New Senior Hires Expand Its Advisory Reach?

Lazard (LAZ) has been busy reshaping its senior bench, adding Matt Spence to lead Defense Technology and Emerging Technology, alongside Daniel Burton-Morgan and Niul Wood in newly created advisory leadership roles.

Against this management reshuffle, Lazard’s share price has drifted, with a 30-day share price return of down 17.1% and a year-to-date share price return of down 26.4%, even though the 3-year total shareholder return of 38.24% points to stronger longer term momentum.

Scan how Lazard compares with other financials by reviewing our hand picked list of 29 high quality undervalued stocks, which combines solid cash flows with balance sheets many investors focus on in tougher markets.

Lazard’s boardroom refresh meets a share price that has pulled back hard. Does that recent slide leave more upside than downside for new buyers, once you line it up against today’s valuation markers?

Most Popular Narrative: 23% Undervalued

Lazard last closed at $36.60, while the most followed narrative anchors on a fair value near $47.38, which frames the recent share price pullback very differently from the market tape.

Lazard's diversification in M&A, non-M&A, and global operations allows the firm to adapt to changing market conditions and capture opportunities across different regions, potentially stabilizing revenues amidst economic uncertainties.

Growth in Lazard's financial advisory backlog, particularly in Europe, combined with a diversified business model across geographic and product lines, could buoy revenues even if specific markets face challenges.

See why 4 investors see Lazard as 23% undervalued.

Result: Fair Value of $47.38 (UNDERVALUED)

Still, Lazard’s heavier spending on new offices, alliances and senior hires could weigh on profitability if advisory backlogs or asset management inflows do not materialise as expected.

Find out about the key risks to this Lazard narrative.

Next Steps

If this mix of enthusiasm and caution around Lazard feels familiar, use it as a prompt to move fast and test the numbers yourself. Then weigh both sides of the story against the 4 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Lazard?

Do not stop with Lazard. Put this research to work by lining up fresh watchlist candidates that fit your risk tolerance and return goals before the next move happens.

• Zero in on potential mispricings and compare what you see in Lazard with a broader set of opportunities using the 29 high quality undervalued stocks.
• Prioritize resilience over drama by scanning a 30 resilient stocks with low risk scores that can help you balance out more volatile positions in your portfolio.
• Target financial strength first, then story, by filtering for companies that pass tough quality checks using our list of solid balance sheet and fundamentals (23 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com